检索结果 - Sachdev Thomas

  • Showing 1 - 13 results of 13
Refine Results
  1. 1
    Goblet cell carcinoid of the appendix – diagnostic challenges and treatment updates: a case report and review of the literature

    Goblet cell carcinoid of the appendix – diagnostic challenges and treatment updates: a case report and review of the literature 由 Gilmore, Gregory, Jensen, Kristin, Saligram, Shreyas, Sachdev, Thomas P., Arekapudi, Subramanyeswara R.

    出版 2018
    获取全文 获取全文 获取全文
    Text
    加到收藏夹
    Saved in:
  2. 2
    Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2

    Randomized Phase II Trial of Erlotinib or Standard Chemotherapy in Patients With Advanced Non–Small-Cell Lung Cancer and a Performance Status of 2 由 Rogério Lilenbaum, Rita Axelrod, Sachdev Thomas, Afshin Dowlati, L. Seigel, Donald G. Albert, Karsten Witt, D. Botkin

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  3. 3
    A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503

    A phase II trial of Triapine® (NSC# 663249) and gemcitabine as second line treatment of advanced non-small cell lung cancer: Eastern Cooperative Oncology Group Study 1503 由 Anne M. Traynor, Ju-Whei Lee, Gerald K. Bayer, John M. Tate, Sachdev Thomas, Miroslaw Mazurczak, David L. Graham, Jill Kolesar, Joan H. Schiller

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  4. 4
    Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Central Cancer Treatment Group Study N05C5

    Placebo-Controlled Trial to Determine the Effectiveness of a Urea/Lactic Acid–Based Topical Keratolytic Agent for Prevention of Capecitabine-Induced Hand-Foot Syndrome: North Centr... 由 Sherry L. Wolf, Rui Qin, Smitha Menon, Kendrith M. Rowland, Sachdev Thomas, Robert Delaune, Diana L. Christian, Eduardo R. Pajon, Daniel Satele, Jeffrey L. Berenberg, Charles L. Loprinzi

    出版 2010
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  5. 5
    Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer

    Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Risedronate for the Prevention of Bone Loss in Premenopausal Women Undergoing Chemotherapy for Primary Breast Cancer 由 Stephanie L. Hines, Betty A. Mincey, Jeff A. Sloan, Sachdev Thomas, Elaine G. Chottiner, Charles L. Loprinzi, Mark D. Carlson, Philip J. Atherton, Muhammad Salim, Edith A. Perez

    出版 2008
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  6. 6
    Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer

    Carboplatin and Paclitaxel in Combination With Either Vorinostat or Placebo for First-Line Therapy of Advanced Non–Small-Cell Lung Cancer 由 Suresh S. Ramalingam, Michael L. Maitland, Paul Frankel, Athanassios Argiris, Marianna Koczywas, Barbara J. Gitlitz, Sachdev Thomas, Igor Espinoza‐Delgado, Everett E. Vokes, David R. Gandara, Chandra P. Belani

    出版 2009
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  7. 7
    <i>TP53</i> Gain-of-Function and Non–Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma

    <i>TP53</i> Gain-of-Function and Non–Gain-of-Function Mutations Are Associated With Differential Prognosis in Advanced Pancreatic Ductal Adenocarcinoma 由 Minggui Pan, Chen Jiang, Zheyang Zhang, Ninah Achacoso, Stacey E. Alexeeff, Aleyda V. Solorzano, Pam Tse, Elaine Chung, Tilak Sundaresan, Jennifer M. Suga, Sachdev Thomas, Laurel A. Habel

    出版 2023
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  8. 8
    Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium

    Cediranib in patients with malignant mesothelioma: A phase II trial of the University of Chicago Phase II Consortium 由 Nicholas Campbell, Rangesh Kunnavakkam, Natasha B. Leighl, Mark Vincent, David R. Gandara, Marianna Koczywas, Barbara J. Gitlitz, Edem Agamah, Sachdev Thomas, Walter M. Stadler, Everett E. Vokes, Hedy L. Kindler

    出版 2012
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  9. 9
    Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (Alliance)

    Chemotherapy With or Without Maintenance Sunitinib for Untreated Extensive-Stage Small-Cell Lung Cancer: A Randomized, Double-Blind, Placebo-Controlled Phase II Study—CALGB 30504 (... 由 Neal Ready, Herbert Pang, Lin Gu, Gregory A. Otterson, Sachdev Thomas, Antonius A. Miller, Maria Q. Baggstrom, Gregory A. Masters, Stephen L. Graziano, Jeffrey Crawford, Jeffrey A. Bogart, Everett E. Vokes

    出版 2015
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:
  10. 10
    <i>TP53</i> Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer

    <i>TP53</i> Gain-of-Function and Non–Gain-of-Function Mutations Are Differentially Associated With Sidedness-Dependent Prognosis in Metastatic Colorectal Cancer 由 Minggui Pan, Chen Jiang, Pam Tse, Ninah Achacoso, Stacey E. Alexeeff, Aleyda V. Solorzano, Elaine Chung, Wenwei Hu, Thach‐Giao Truong, Amit Arora, Tilak Sundaresan, Jennifer M. Suga, Sachdev Thomas, Laurel A. Habel

    出版 2021
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  11. 11
    Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexpression: CALGB 30801 (Alliance)

    Phase III Randomized, Placebo-Controlled, Double-Blind Trial of Celecoxib in Addition to Standard Chemotherapy for Advanced Non–Small-Cell Lung Cancer With Cyclooxygenase-2 Overexp... 由 Martin J. Edelman, Xiaofei Wang, Lydia Hodgson, Richard T. Cheney, Maria Q. Baggstrom, Sachdev Thomas, Ajeet Gajra, Erin M. Bertino, Karen L. Reckamp, Julian R. Molina, Joan H. Schiller, Kisha Mitchell-Richards, Paula N. Friedman, Jon Ritter, Ginger L. Milne, Olwen Hahn, Thomas E. Stinchcombe, Everett E. Vokes

    出版 2017
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  12. 12
    Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial

    Phase II Study of the Oral MEK Inhibitor Selumetinib in Advanced Acute Myelogenous Leukemia: A University of Chicago Phase II Consortium Trial 由 Nitin Jain, Emily Curran, Neil M. Iyengar, Ernesto Díaz-Flores, Rangesh Kunnavakkam, Leslie Popplewell, Mark Kirschbaum, Theodore Karrison, Harry P. Erba, Margaret Green, Xavier Poiré, Greg Koval, Kevin Shannon, Poluru L. Reddy, Loren Joseph, Ehab Atallah, Philip A. Dy, Sachdev Thomas, Scott E. Smith, L. Austin Doyle, Walter M. Stadler, Richard A. Larson, Wendy Stock, Olatoyosi Odenike

    出版 2013
    获取全文
    Artigo
    加到收藏夹
    Saved in:
  13. 13
    Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit

    Development and validation of an integrative pan-solid tumor predictor of PD-1/PD-L1 blockade benefit 由 Scott A. Tomlins, Nickolay A. Khazanov, Benjamin J. Bulen, Daniel H. Hovelson, Melissa J. Shreve, Laura E. Lamb, Marc Matrana, Mark E. Burkard, Eddy S. Yang, William J. Edenfield, Elizabeth Claire Dees, Adedayo A. Onitilo, Michael A. Thompson, Gary L. Buchschacher, Alan M. Miller, Alexander Menter, Benjamin M. Parsons, Timothy R. Wassenaar, Leon C. Hwang, Jennifer M. Suga, Robert D. Siegel, William Irvin, Suresh Nair, Jennifer N. Slim, Jamal Misleh, Jamil Khatri, Gregory A. Masters, Sachdev Thomas, Malek M. Safa, Daniel M. Anderson, Kat Kwiatkowski, Khalis Mitchell, T. Hu-Seliger, Stephanie Drewery, Andrew Fischer, Komal Plouffe, Eric Czuprenski, Jennifer Hipp, Travis Reeder, Hana Vakil, D. Bryan Johnson, Daniel R. Rhodes

    出版 2023
    获取全文 获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: